Beneficial effect of mindfulness based stress reduction on optic disc perfusion in primary open angle glaucoma: A randomized controlled trial

10.1016/j.jtcme.2021.06.006

Tanuj Dada；Brajesh Lahri；Karthikeyan Mahalingam；Jyoti Shakrawal；Atul Kumar；Ramanjit Sihota；Raj Kumar Yadav

Optic disc perfusion ； Meditation ； Glaucoma ； Stress reduction ； OCTA

Journal of Traditional and Complementary Medicine

11卷6期（2021 / 11 / 01）

581 - 586

英文

Background and aim: Glaucoma is one of the leading causes of visual impairment worldwide. Next to intraocular pressure (IOP), vascular factors play a major role in glaucoma. Mindfulness-based stress reduction (MBSR) has been shown to reduce the IOP, normalize the stress biomarkers, modulate gene expression, and also improve the quality of life. This study was aimed to assess the effect of MBSR in optic disc perfusion of patients with primary open angle glaucoma (POAG). Experimental procedure: POAG patients with controlled IOP (＜21 mmHg) were randomised in to intervention group (n = 30) and control group (n = 30). Both the groups continued their routine glaucoma medications while the intervention group practiced 45 min of MBSR every day in addition. IOP and optic disc perfusion using OCT-Angiography were recorded at baseline and at 6 weeks for both the groups. Results: The mean age of the participants were 53.23 ± 8.4yr in intervention and 50.23 ± 7.3yr in the control group (p = 0.06). All the baseline parameters were comparable in both groups. After MBSR, in the intervention group there was a significant reduction of IOP (p=0.001), increase in circum-papillary vessel density in superior quadrant (15.8%-17.4%, p=0.02) and nasal quadrant (14.2%-16.5%, p=0.01), increase in circum papillary vascular perfusion, in superior quadrant (38.9%-41.1%, p＜0.001), in temporal quadrant (42.2%-44.5%, p＜0.001), in inferior quadrant (40.1%-43.8%, p＜0.001), and in nasal quadrant (40.6%-42.8%, p＜0.001). There was also a significant increase in Flux Index after 6weeks (0.38-0.40, p＜0.001). Conclusion: MBSR can reduce barotrauma and improve optic disc perfusion in POAG patients and serve as a useful adjunct to the standard medical therapy.

1. Abe, RY,Silva, TC,Dantas, I(2020).Can psychologic stress elevate intraocular pressure in healthy individuals?.Ophthalmol Glaucoma,3(6),426-433.
2. Azam, MA,Katz, J,Fashler, SR,Changoor, T,Azargive, S,Ritvo, P(2015).Heart rate variability is enhanced in controls but not maladaptive perfectionists during brief mindfulness meditation following stress-induction: a stratified-randomized trial.Int J Psychophysiol Off J Int Organ Psychoph,98(1),27-34.
3. Bourne, RRA,Jonas, JB,Bron, AM(2018).Prevalence and causes of vision loss in high-income countries and in Eastern and Central Europe in 2015: magnitude, temporal trends and projections.Br J Ophthalmol,102(5),575-585.
4. Cavet, ME,Vittitow, JL,Impagnatiello, F,Ongini, E,Bastia, E(2014).Nitric oxide (NO): an emerging target for the treatment of glaucoma.Invest Ophthalmol Vis Sci.,55(8),5005-5015.
5. Chen, HS-L,Liu, C-H,Wu, W-C,Tseng, H-J,Lee, Y-S(2017).Optical coherence tomography angiography of the superficial microvasculature in the macular and peri-papillary areas in glaucomatous and healthy eyes.Invest Ophthalmol Vis Sci,58(9),3637-3645.
6. Cheng, CY,Liu, CJ,Chiou, HJ,Chou, JC,Hsu, WM,Liu, JH(2001).Color Doppler imaging study of retrobulbar hemodynamics in chronic angle-closure glaucoma.Ophthalmology,108(8),1445-1451.
7. Clark, CV,Mapstone, R(1986).Systemic autonomic neuropathy in open-angle glau-coma.Doc Ophthalmol Adv Ophthalmol,64(2),179-185.
8. Dada, T,Bhai, N,Midha, N(2020).Effect of mindfulness meditation on intraocular pressure and trabecular meshwork gene expression: a randomised controlled trial.Am J Ophthalmol
9. Dada, T,Mahalingam, K,Gupta, V(2020).Allostatic load and glaucoma: are we missing the big picture?.J Curr Glaucoma Pract,14(2),47-49.
10. Dada, T,Mittal, D,Mohanty, K(2018).Mindfulness meditation reduces intraocular pressure, lowers stress biomarkers and modulates gene expression in glaucoma: a randomized controlled trial.J Glaucoma,27(12),1061-1067.
11. Dada, T,Ramesh, P,Shakrawal, J(2020).Meditation: a polypill for comprehensive management of glaucoma patients.J Glaucoma,29(2),133-140.
12. Erdurmuş, M,Yağcı, R,Atış, Ö,Karadağ, R,Akbaş, A,Hepşen, IF(2011).Antioxidant status and oxidative stress in primary open angle glaucoma and pseudoexfoliative glaucoma.Curr Eye Res,36(8),713-718.
13. Flammer, J,Konieczka, K,Flammer, AJ(2013).The primary vascular dysregulation syndrome: implications for eye diseases.EPMA J.,4(1),14.
14. Flammer, J,Orgül, S(1998).Optic nerve blood-flow abnormalities in glaucoma.Prog Retin Eye Res.,17(2),267-289.
15. Flammer, J,Orgül, S,Costa, VP(2002).The impact of ocular blood flow in glau-coma.Prog Retin Eye Res.,21(4),359-393.
16. Gagrani, M,Faiq, MA,Sidhu, T(2018).Meditation enhances brain oxygenation, upregulates BDNF and improves quality of life in patients with primary open angle glaucoma: a randomized controlled trial.Restor Neurol Neurosci,36(6),741-753.
17. Gugleta, K,Orgül, S,Flammer, J(1999).Is corneal temperature correlated with blood-flow velocity in the ophthalmic artery?.Curr Eye Res,19(6),496-501.
18. Gupta, N,Yücel, YH(2007).What changes can we expect in the brain of glaucoma patients?.Surv Ophthalmol,52(Suppl 2),S122-S126.
19. Holló, G(2017).Influence of large intraocular pressure reduction on peripapillary OCT vessel density in ocular hypertensive and glaucoma eyes.J Glaucoma,26(1),e7-e10.
20. Kass, MA,Heuer, DK,Higginbotham, EJ(1960).The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma.Arch Ophthalmol Chic Ill,120(6),701-713.
21. Kemper, KJ,Powell, D,Helms, CC,Kim-Shapiro, DB(2015).Loving-kindness meditation's effects on nitric oxide and perceived well-being: a pilot study in experienced and inexperienced meditators.Explore N Y N,11(1),32-39.
22. Kurysheva, NI,Shlapak, VN,Ryabova, TY(2018).Heart rate variability in normal tension glaucoma: a case-control study.Medicine,97(5),e9744.
23. Kutz, I,Borysenko, JZ,Benson, H(1985).Meditation and psychotherapy: a rationale for the integration of dynamic psychotherapy, the relaxation response, and mindfulness meditation.Am J Psychiatr,142(1),1-8.
24. Lauritzen, M(2001).Relationship of spikes, synaptic activity, and local changes of cerebral blood flow.J Cereb Blood Flow Metab Off J Int Soc Cereb Blood Flow Metab,21(12),1367-1383.
25. Li, Z,Xu, Z,Liu, Q,Chen, X,Li, L(2020).Comparisons of retinal vessel density and glaucomatous parameters in optical coherence tomography angiography.PloS One.,15(6),e0234816.
26. Logean, E,Geiser, MH,Petrig, BL,Riva, CE(1997).Portable ocular laser Doppler red blood cell velocimeter.Rev Sci Instrum,68(7),2878-2882.
27. Mahalingam, K,Chaurasia, AK,Gowtham, L(2018).Therapeutic potential of valproic acid in advanced glaucoma: a pilot study.Indian J Ophthalmol,66(8),1104-1108.
28. Newberg, AB,Iversen, J(2003).The neural basis of the complex mental task of meditation: neurotransmitter and neurochemical considerations.Med Hypotheses,61(2),282-291.
29. Rao, HL,Srinivasan, T,Pradhan, ZS(2020).Optical coherence tomography angiography and visual field progression in primary angle closure glaucoma.J Glaucoma
30. Sabel, BA,Flammer, J,Merabet, LB(2018).Residual vision activation and the brain-eye-vascular triad: dysregulation, plasticity and restoration in low vision and blindness - a review.Restor Neurol Neurosci,36(6),767-791.
31. Sabel, BA,Wang, J,Cárdenas-Morales, L,Faiq, M,Heim, C(2018).Mental stress as consequence and cause of vision loss: the dawn of psychosomatic ophthal-mology for preventive and personalized medicine.EPMA J.,9(2),133-160.
32. Schmidl, D,Boltz, A,Kaya, S(2013).Role of nitric oxide in optic nerve head blood flow regulation during isometric exercise in healthy humans.Invest Ophthalmol Vis Sci.,54(3),1964-1970.
33. Toda, N,Nakanishi-Toda, M(2007).Nitric oxide: ocular blood flow, glaucoma, and diabetic retinopathy.Prog Retin Eye Res.,26(3),205-238.
34. Vasudevan, SK,Gupta, V,Crowston, JG(2011).Neuroprotection in glaucoma.Indian J Ophthalmol,59(7),102.
35. Weber, AJ,Chen, H,Hubbard, WC,Kaufman, PL(2000).Experimental glaucoma and cell size, density, and number in the primate lateral geniculate nucleus.Invest Ophthalmol Vis Sci.,41(6),1370-1379.
36. Weindler, H,Spitzer, MS,Schultheiß, M,Kromer, R(2020).OCT angiography analysis of retinal vessel density in primary open-angle glaucoma with and without Tafluprost therapy.BMC Ophthalmol,20(1),444.
37. Weinreb, RN,Aung, T,Medeiros, FA(2014).The pathophysiology and treatment of glaucoma: a review.J Am Med Assoc.,311(18),1901-1911.
38. Yokoyama, Y,Aizawa, N,Chiba, N(2011).Significant correlations between optic nerve head microcirculation and visual field defects and nerve fiber layer loss in glaucoma patients with myopic glaucomatous disk.Clin Ophthalmol Auckl NZ,5,1721-1727.
39. Yücel, YH,Zhang, Q,Weinreb, RN,Kaufman, PL,Gupta, N(2003).Effects of retinal ganglion cell loss on magno-, parvo-, koniocellular pathways in the lateral geniculate nucleus and visual cortex in glaucoma.Prog Retin Eye Res,22(4),465-481.
40. Zhang, S,Wu, C,Liu, L(2017).Optical coherence tomography angiography of the peripapillary retina in primary angle-closure glaucoma.Am J Ophthalmol,182,194-200.